G1 Therapeutics IncEigentümerstruktur
| Preis (2024-09-17) | 52W Hoch | 52W Tief |
| 7.15 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 9,5 USD | 1 | 0 | 4 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 52.758.200 | 6,52 | 1,01 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name G1 Therapeutics Inc
Mitarbeiter 100
Handelsplatz NASDAQ
Ticker Symbol GTHX
IPO Datum 2017-05-17
Adresse 700 Park Offices Drive, Research Triangle Park, NC, United States, 27709
Webseite https://www.g1therapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. John E. Bailey Jr. | CEO, President & Director |
| 2 | Dr. Rajesh K. Malik Ch.B., M.B., M.D. | Chief Medical Officer |
| 3 | Mr. Mark Avagliano | Chief Business Officer |
| 4 | Mr. John W. Umstead V | Chief Financial Officer |
| 5 | Mr. Terry L. Murdock MSc | Chief Operating Officer |
| 6 | Mr. William C. Roberts | Vice President of Investor Relations & Corporate Communications |
| 7 | Ms. Monica Roberts Thomas | Chief Legal & People Officer |
| 8 | Mr. Evan Hicks M.B.A. | Vice President of Marketing |
| 9 | Mr. Andrew Perry | Chief Commercial Officer |
| 10 | Mr. Jeff Macdonald | Senior Director of Investor Relations & Corporate Communications |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 3 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 6 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 7 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 8 | Connor Clark & Lunn Inv Mgmt Ltd | 0,00% | 0,00 Mio. USD |
| 9 | Jacobs Levy Equity Management, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | Bridgeway Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 12 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 14 | Readystate Asset Management LP | 0,00% | 0,00 Mio. USD |
| 15 | Caption Management, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Needham Investment Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Bank of New York Mellon Corp | 0,00% | 0,00 Mio. USD |
| 18 | Man Group PLC | 0,00% | 0,00 Mio. USD |
| 19 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 20 | Birchview Capital, LP | 0,00% | 0,00 Mio. USD |